Hope and Hype around Immunotherapy in Triple-Negative Breast Cancer

SIMPLE SUMMARY: Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype accounting for approximately 10–20% of all cases. Due to a lack of actionable targets, chemotherapy has been for many decades the preferred, and often the only, available treatment option for this disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobs, Flavia, Agostinetto, Elisa, Miggiano, Chiara, De Sanctis, Rita, Zambelli, Alberto, Santoro, Armando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252021/
https://www.ncbi.nlm.nih.gov/pubmed/37296893
http://dx.doi.org/10.3390/cancers15112933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252021/
https://www.ncbi.nlm.nih.gov/pubmed/37296893
http://dx.doi.org/10.3390/cancers15112933

Ejemplares similares